Unlearn.AI
Harnessing data, AI, and digital twins to transform clinical development
San Francisco, United States · Founded 2017 · $116.8M raised
- Headquarters
- San Francisco, California
- Employees
- 51–200
- Founded
- 2017
- Business Model
- B2B
- Website
- unlearn.ai
- Total Funding
- $116.8M
- Last Round
- $50.0M Series CFeb 2024
- Rounds
- 5
About
Unlearn.AI harnesses data, AI, and digital twins to transform clinical development. Their TwinRCT technology creates AI-generated digital twins of trial participants, enabling smaller, more robust randomized controlled trials that bring life-saving treatments to patients faster. Partnered with leading pharma companies globally.
Summary
Unlearn.AI is an Artificial Intelligence company based in San Francisco, United States, founded in 2017. It has raised $116.8M in total across 5 rounds, most recently a $50.0M Series C round in Feb 2024. Investors include DCVC (Data Collab), Altimeter Capital and Radical Ventures.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Feb 2024
Sign up to see all 5 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company